A large number of oral antidiabetic drugs aimed to eliminate three major metabolic disorders leading to hyperglycemia-dysfunction of β-cells, peripheral insulin resistance, excessive hepatic glucose production [4, 5]. The gene discussed is INS; the disease is Hyperglycemia.